BACKGROUND: Coagulation factor XI (FXI) inhibitors are a promising and novel class of anticoagulants, but a recent animal study found that FXI inhibition exacerbated diastolic dysfunction and heart ...

BACKGROUND: Cardiomyocytes in the adult human heart show a regenerative capacity, with an annual renewal rate of ≈0.5%. Whether this regenerative capacity of human cardiomyocytes is employed in heart ...

The ability to characterize the pulmonary circulation more fully paved the way for many advances. In the 1950s, Dr David ...

Codeveloped by the American Heart Association and the American Red Cross, these guidelines represent the first comprehensive ...

Our vision is to innovate and incorporate promising technologies to communicate freely available, high-priority, high-quality content, which accelerates scientific progress and advances heart and ...

BACKGROUND: Patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction commonly experience ...

Kawasaki disease (KD), an acute self-limited febrile illness that primarily affects children <5 years old, is the leading cause of acquired heart disease in developed countries, with the potential of ...

Leading coronary artery, structural heart, and vascular disease science that advances practice and improves patient outcomes ...

Professional Heart Daily provides comprehensive information about Scientific Sessions, including the full program, detailed conference coverage, and more. Non late-breaking abstracts are available as ...

BACKGROUND: Blood pressure (BP)–lowering effects of structured exercise are well-established. Effects of 24-hour movement ...

BACKGROUND: Many studies have explored whether individual plasma protein biomarkers improve cardiovascular disease risk ...